Copyright
©The Author(s) 2022.
World J Diabetes. Aug 15, 2022; 13(8): 600-612
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.600
Published online Aug 15, 2022. doi: 10.4239/wjd.v13.i8.600
Figure 2 Clopidogrel improves the kidney function of db/db mice.
Data are shown as mean ± SD values of n = 6 mice per group. aP < 0.05 vs wild type mice; bP < 0.05 vs db/db mice. A: Urinary albumin/creatinine ratio. Mice at 12 wk of age were defined as the baseline; B: Periodic acid-Schiff staining of kidney sections for glycogen content and Masson’s trichrome staining for collagenous connective tissue fibers. Magnification: × 400. WT: Wild type; db/db: db/db mice; Clo: Clopidogrel; Clo (L, M, H): Clopidogrel at 5, 10, or 20 mg/kg, respectively.
- Citation: Li HQ, Liu N, Zheng ZY, Teng HL, Pei J. Clopidogrel delays and can reverse diabetic nephropathy pathogenesis in type 2 diabetic db/db mice. World J Diabetes 2022; 13(8): 600-612
- URL: https://www.wjgnet.com/1948-9358/full/v13/i8/600.htm
- DOI: https://dx.doi.org/10.4239/wjd.v13.i8.600